Clinical Trials Directory

Trials / Completed

CompletedNCT04206241

Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe

Status
Completed
Phase
Study type
Observational
Enrollment
278,833 (actual)
Sponsor
Elizabeth Glaser Pediatric AIDS Foundation · Academic / Other
Sex
All
Age
48 Hours
Healthy volunteers
Accepted

Summary

This study aims to assess the feasibility and, acceptability and effects of implementing HIV testing at birth testing using point-of-care (POC) HIV nucleic acid testing (NAT) in maternity settings.

Detailed description

This Unitaid-funded study aims to assess the feasibility and, acceptability and effects of implementing HIV testing at birth testing using point-of-care (POC) HIV nucleic acid testing (NAT) in maternity settings. Outcomes measures will include age at uptake of testing, turnaround time from testing to caregiver result receipt, HIV positivity rate, and timing of ART initiation for HIV-positive infants. This study will compare outcomes between HIV-exposed at high vs low risk of maternal HIV transmission. The study will also assess the impact of POC birth testing on retention in care and impact on subsequent testing at 6 weeks.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPoint of care early infant diagnosis (POC EID)HIV testing where the blood sample is processed at either the facility itself or a nearby site that is closer to the facility than a laboratory. With POC EID, blood samples do not have to travel to the laboratory for processing.

Timeline

Start date
2018-01-01
Primary completion
2018-11-01
Completion
2019-12-31
First posted
2019-12-20
Last updated
2021-08-18

Locations

10 sites across 1 country: Zimbabwe

Source: ClinicalTrials.gov record NCT04206241. Inclusion in this directory is not an endorsement.